Page 80 - GPD-3-4
P. 80

Gene & Protein in Disease                                    Interleukins-1β, interleukin-8, and the SARS-CoV-2



            IL-8,  IP-10,  and  MCP-1  as  well  as  with  the  period  of   emphasize the importance of mass vaccination against
            onset of symptoms and clinical signs and analysis of these   COVID-19 in containing the disease, resulting in changes
            cytokines. 6,21                                    in the patterns of hospitalizations and deaths and leading
              According to the results shown in Table 1, the mean   to an overall reduction in the rate of hospitalizations and
            interval between  the onset of  clinical signs and  sample   deaths, primarily in patients aged 60 – 69 years. 26,27
            collection may influence the analysis of the gene expression   The  ND  group  showed  the  occurrence  of  all  the
            of ILs. The ND group showed the highest mean expression   abovementioned comorbidities and conditions, in addition
            of all ILs as well as a higher mean and standard deviation in   to being the group with the highest reported mean age,
            the interval between the onset of clinical signs and sample   which might have contributed to a greater pre-disposition
            collection of 5.22 (±2.38) days compared with those in the   to comorbidities and a greater probability of aggravation
            DVAC (3.92 [±1.48] days) and DNVAC (4.44 [±1.44] days)   of COVID-19. The increased incidence of complications
            groups. It is evident that this study was conducted at the   and  deaths  is  reported  to  be  higher  in  individuals  with
            beginning of the COVID-19 pandemic, respecting what   risk  factors  and  comorbidities,  especially  in  those  aged
            was initially recommended by the Ministry of Health for the   >60 years. 28
            diagnosis of the disease by RT-PCR, because the literature   Among the comorbidities and risk factors evaluated
            we reviewed shows that such ILs tend to be significantly   in our study, we observed a higher frequency of chronic
            increased in longer varieties. 12,21  Wong  et al. (2004)   cardiovascular disease, asthma/chronic lung disease,
            reported an increase in the levels of pro-inflammatory   diabetes, obesity, cancer, and smoking in the analyzed
            cytokines such as IL-1β, IL-6, and IL-12 after 5 – 12 days   groups. Mercês  et al.  reported higher mortality from
                                                                                 29
            from the onset of symptoms of SARS, whereas an increase   COVID-19 in individuals aged 70 – 79  years with
            in IL-8 levels was primarily observed after 9 – 14 days from   comorbidities, primarily heart disease and diabetes. Tang
            the onset of symptoms of the syndrome. 21
                                                               et al.  found a higher occurrence of diabetes (20%),
                                                                   30
              As observed in this study, other studies 6,12,22,23  that   hypertension and cardiovascular disease (15%), chronic
            examined patients with COVID-19 reported that fever,   obstructive pulmonary disease (2%), chronic liver disease
            cough, fatigue, sore throat, headache, conjunctival   (2%), and cancer (2%) in patients with COVID-19. Similar
            congestion, and dyspnea were the most frequent clinical   to our study, Das Mercês et al. found a higher incidence
            signs and symptoms in patients with influenza syndrome   of cardiopathies, diabetes, kidney disease, pneumopathy,
            or SARS. However, these symptoms are non-specific, and   immunosuppression, obesity, and asthma in individuals
            therefore, it is difficult to differentiate them from those of   with COVID-19. 29
            other respiratory syndromes, as observed in the ND group   The greater pre-disposition of individuals with chronic
            of this study. Similarly, Chen et al.  reported that 82% of   comorbidities to progress into severe cases of COVID-19
                                        23
            patients with COVID-19 had fever and cough, 31% had   is because these individuals tend to have greater expression
            shortness of breath, 11% had muscle pain (myalgia), 8%
            had headache, 5% had sore throat, 2% had diarrhea, and   of ACE-2 genes, which are responsible for the synthesis of
            1% had vomiting. Moreira  described a symptomatology   the ACE-2 surface protein that acts as the major receptor
                                 24
                                                               for binding SARS-CoV-2 and establishing the infectious
            similar to that observed in the present study, showing   process.  This  phenomenon  tends  to  occur  primarily  in
            that the most common clinical signs and symptoms at the   individuals with chronic cardiovascular disorders and
            onset of the disease are fever, cough, and fatigue, and as   31
            the disease develops and worsens, the symptoms include   diabetes.
            sputum production, headache, hemoptysis, diarrhea, and   The results of this study indicate a statistical significance
            dyspnea.                                           for the comorbidity/risk factor cancer, which makes
                                                               patients more vulnerable  to  injury  and  lethality  due  to
              In the present study, most clinical signs and symptoms
            showed a reduced frequency in the DVAC group compared   COVID-19, especially those with lung and hematologic
                                                                       32
            with that in the DNVAC group, indicating a possible   neoplasia.
            influence of vaccination against COVID-19 on the     The need for hospitalizations and treatment in the
            symptomatology of the disease. Data from the Butantan   ICU raises concerns regarding the high mortality rate of
            Institute  show that older patients suffer a higher lethality   these patients. This study showed that the ND group had
                  25
            due to COVID-19 and that vaccinated individuals have   higher gene expression of the investigated ILs and greater
            a 40.4% lower lethality rate than unvaccinated patients   severity of the clinical condition. De Sousa et al.  found
                                                                                                       33
            because the vaccines can reduce the severity of the disease   that hospitalized patients with COVID-19, primarily in
            and consequently evolution to death. Other researchers   the interior regions of Brazil, had higher lethality among


            Volume 3 Issue 4 (2024)                         6                               doi: 10.36922/gpd.4076
   75   76   77   78   79   80   81   82   83   84   85